Abstract
SYNOPSISPizotifen, a tricyclic antiserotonin agent and inhibitor of certain other biogenic amines, was effective in reducing the severity and frequency of migraine attacks, producing complete remission in some cases, in a double‐blind placebo controlled trial in 36 patients. Serious side effects were not reported during the trial period.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
